Related Experiment Video

Updated: Aug 29, 2026

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer
07:59

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

Small cell lung cancer: from molecular biology to novel therapeutics

Evan Pisick1, Simha Jagadeesh, Ravi Salgia

  • 1Tufts- New England Medical Center, Tufts University School of Medicine, Boston, MA, USA.

Journal of Experimental Therapeutics & Oncology
|December 18, 2003
PubMed

Insights

Small cell lung cancer (SCLC) is an aggressive malignancy with early metastasis and poor prognosis. This review updates the molecular and cellular biology, treatment strategies, and novel therapeutics for SCLC.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Small cell lung cancer (SCLC) is characterized by its aggressive nature and early metastatic potential.
  • Patients diagnosed with SCLC often face a poor prognosis, necessitating extensive research into the disease.
  • The rapid progression and poor outcomes underscore the need for a comprehensive understanding of SCLC biology and treatment.

Purpose of the Study:

  • To provide an updated review of the molecular and cellular biology of SCLC.
  • To discuss the relationship between cellular pathways and cellular function in SCLC.
  • To cover current and novel therapeutic approaches for SCLC, including chemotherapy, radiotherapy, surgery, and emerging treatments.

Main Methods:

  • Literature review and synthesis of current research on SCLC.
  • Analysis of molecular and cellular mechanisms driving SCLC progression.
  • Examination of established and investigational treatment modalities for SCLC.

Main Results:

  • SCLC exhibits complex molecular and cellular characteristics contributing to its aggressive phenotype.
  • Understanding cellular pathways is crucial for elucidating SCLC pathogenesis.
  • Current treatments include chemotherapy, thoracic radiotherapy, and surgery, with ongoing research into novel therapeutics.

Conclusions:

  • A comprehensive understanding of SCLC biology is essential for improving patient outcomes.
  • Multimodal treatment strategies are employed for different stages of SCLC.
  • Novel therapeutic agents hold promise for advancing SCLC treatment paradigms.

More Related Videos

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing05:17

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing

Published on: October 10, 2025

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...